Sort
16,300 grants matching “fatty liver disease”
Cell Signaling: Macrovascular Complications of Diabetes
$378,690Karin E. Bornfeldt · University Of Washington · R01 · FY2009 · HL
Cell Signaling: Macrovascular Complications of Diabetes
$378,690Karin E. Bornfeldt · University Of Washington · R01 · FY2008 · HL
Regulation of Circadian Metabolism by the Hepatic Transcription Factor CREBH
$378,648Kezhong Zhang · Wayne State University · R01 · FY2017 · DK
The Role of G Proteins in Insulin Action
$378,608Alan R. Saltiel · University Of Michigan At Ann Arbor · R01 · FY2014 · DK
Control of lipid metabolism in insulin resistant states
$378,450Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2012 · DK
The Role of ChREBP in Fructose Induced Metabolic Disease
$378,450Mark A Herman · Beth Israel Deaconess Medical Center · R01 · FY2015 · DK
Control of lipid metabolism in insulin resistant states
$378,450Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2015 · DK
Control of lipid metabolism in insulin resistant states
$378,450Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2014 · DK
The Role of ChREBP in Fructose Induced Metabolic Disease
$378,450Mark A Herman · Beth Israel Deaconess Medical Center · R01 · FY2014 · DK
Molecular Physiology of Liver Fatty Acid Transporters
$378,442Andreas Stahl · University Of California Berkeley · R56 · FY2009 · DK
Cell Signaling: Macrovascular Complications of Diabetes
$378,387Karin E. Bornfeldt · University Of Washington · R01 · FY2007 · HL
Monitoring Hepatitis and Cirrhosis by 23Na MRS/MRI
$378,368Navin Bansal · Indiana University Indianapolis · R01 · FY2009 · EB
Microbiome, metabolites, and alcohol in HIV to reduce CVD Cohort (META HIV CVD Cohort)
$378,345Kaku So-Armah · Vanderbilt University Medical Center · P01 · FY2022 · AA
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
$378,324Natalia Nieto · Icahn School Of Medicine At Mount Sinai · U01 · FY2013 · AA
Chemical approach to study autopalmitoylation of transcription factors
$378,270Xu Wu · Massachusetts General Hospital · R01 · FY2019 · DK
Chemical approach to study autopalmitoylation of transcription factors
$378,270Xu Wu · Massachusetts General Hospital · R01 · FY2017 · DK
Chemical approach to study autopalmitoylation of transcription factors
$378,270Xu Wu · Massachusetts General Hospital · R01 · FY2020 · DK
Role of Obesity in Infection
$378,258Salomon Amar · Boston University Medical Campus · R01 · FY2012 · DE
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$378,243Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2011 · DK
Biomarker discovery for mitochondrial toxicants using metabolic footprinting
$378,224David Mark Hockenbery · Fred Hutchinson Cancer Research Center · R01 · FY2012 · ES
Modulation of Acute Liver Injury
$378,223Mark J. Czaja · Albert Einstein College Of Medicine · R01 · FY2013 · DK
Metabolism and Genetics of Hypobetalipoproteinemia
$378,101Washington University · R01 · FY2004 · HL
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C
$378,094Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Post-translational regulation of hepatic uptake transporters in health and disease
$378,081Bruno Hagenbuch · University Of Kansas Medical Center · R01 · FY2025 · GM
Mannose metabolism as a regulator of hepatic stellate cell activation and fibrosis
$378,069Jaime C Chu · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · DK